Clinical Findings and Anti-Neuronal Antibodies in Coeliac Disease with Neurological Disorders

Clinical Findings and Anti-Neuronal Antibodies in Coeliac Disease with Neurological Disorders2018-01-17T17:06:15-05:00

A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes

A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes2018-01-17T17:06:15-05:00

Induction, acceleration or prevention of autoimmunity by molecular mimicry

Induction, acceleration or prevention of autoimmunity by molecular mimicry2018-01-17T17:06:15-05:00

Inflammation

Inflammation2018-01-17T17:06:15-05:00

Lipoic acid in multiple sclerosis: a pilot study

Lipoic acid in multiple sclerosis: a pilot study2018-01-17T17:06:15-05:00

Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects

Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects2018-01-17T17:06:15-05:00

Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in indian children under 5 years

Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in indian children under 5 years2018-01-17T17:06:15-05:00

Experimental models of neuroprotection relevant to multiple sclerosis

Experimental models of neuroprotection relevant to multiple sclerosis2018-01-17T17:06:15-05:00

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial2018-01-17T17:06:15-05:00

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial2018-01-17T17:06:15-05:00